{"corpus_id":31449428,"paper_sha":"3a10bf75b285668dad98ed7e7a14c04f3767933c","doi":"10.4049/jimmunol.141.4.1108","arxiv_id":null,"pmid":2456340,"pmcid":null,"mag_id":1633531602,"dblp_id":null,"acl_id":null,"title":"Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.","year":1988,"publication_date":"1988-08-15","venue":"Journal of Immunology","journal":{"name":"Journal of immunology","pages":"\n          1108-13\n        ","volume":"141 4"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":0,"citation_count":28,"influential_citation_count":0,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adult","mj":false,"ui":"D000328"},{"d":"Amino Acid Sequence","mj":false,"ui":"D000595"},{"d":"Animals","mj":false,"ui":"D000818"},{"d":"Cell Line, Transformed","mj":false,"ui":"D002461"},{"d":"Cytotoxicity Tests, Immunologic","mj":false,"ui":"D003601"},{"d":"Epitopes","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"},{"q":"immunology","mj":false,"ui":"Q000276"}],"ui":"D000939"},{"d":"Fibroblasts","mj":false,"qs":[{"q":"analysis","mj":false,"ui":"Q000032"}],"ui":"D005347"},{"d":"Genes","mj":false,"ui":"D005796"},{"d":"HLA Antigens","mj":false,"qs":[{"q":"genetics","mj":true,"ui":"Q000235"},{"q":"immunology","mj":false,"ui":"Q000276"}],"ui":"D006680"},{"d":"HLA-A3 Antigen","mj":false,"ui":"D015791"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Influenza A virus","mj":false,"qs":[{"q":"immunology","mj":false,"ui":"Q000276"}],"ui":"D009980"},{"d":"Mice","mj":false,"ui":"D051379"},{"d":"Molecular Sequence Data","mj":false,"ui":"D008969"},{"d":"Mutation","mj":true,"ui":"D009154"},{"d":"Structure-Activity Relationship","mj":false,"ui":"D013329"},{"d":"T-Lymphocytes, Cytotoxic","mj":false,"qs":[{"q":"immunology","mj":true,"ui":"Q000276"},{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D013602"}],"chemicals":[{"n":"Epitopes","ui":"D000939","reg":"0"},{"n":"HLA Antigens","ui":"D006680","reg":"0"},{"n":"HLA-A3 Antigen","ui":"D015791","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://journals.aai.org/jimmunol/article-pdf/141/4/1108/1041571/1108.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/3a10bf75b285668dad98ed7e7a14c04f3767933c","s2_open_access_license":null,"s2_open_access_status":"BRONZE","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The structure-function relationships in human class I HLA molecules have been examined by the analysis of two T cell-defined subtypes of HLA-A3 (A3.1 and A3.2). These subtypes differ by two amino acid residues that are located at positions 152 (GluA3.1 vs ValA3.2) and 156 (LeuA3.1 vs GlnA3.2). By the methods of site-directed mutagenesis and DNA-mediated gene transfer, mammalian cell transfectants have been produced that express only one of the above A3.2 amino acid residues at either position 152 or position 156. Previous studies using murine transfectants have shown that A3.1- and A3.2-expressing cells can be distinguished by A3.1-restricted type A influenza virus-specific CTL and A3.2-allospecific CTL and have implied that amino acid position 152 plays a key role in this specificity. To test whether these results were a function of the virus specificity, the alloantigen, or the cell type expressing the class I molecules, we have tested the recognition of human and murine cell transfectants by A3.1-restricted, A/JAP/305/57 and B/Ann Arbor-specific CTL and by A3.1- and A3.2-allospecific CTL. The results indicate that the Glu at position 152 is critical for recognition by all of the A3.1-restricted CTL populations tested and 15 of 16 of the A3.1-allospecific CTL populations tested. The A3.1 Leu at position 156 was sufficient for recognition by only one A3.1-allospecific CTL line. Substitution of the charged Glu residue for the polar Gln at position 156 of A3.2 affected recognition of some but not all A3.2-alloreactive CTL. These data demonstrate that the structural basis for epitopes that are recognized by almost all CTL that discriminate between A3.1 and A3.2 is primarily the amino acid at position 152. The implications of these data for Ag presentation and CTL recognition are discussed.","claims":[{"public_id":"cl_f87b0e6ec65b2ce9d4d8d5d32d326af9","status":"active","text":"Glu at position 152 is critical for recognition by all tested A3.1-restricted cytotoxic T lymphocyte populations and by 15 of 16 tested A3.1-allospecific cytotoxic T lymphocyte populations.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_f87b0e6ec65b2ce9d4d8d5d32d326af9"},{"public_id":"cl_39fc33942ccd810d102e5a89b36b5f93","status":"active","text":"Substitution of Glu for Gln at position 156 of HLA-A3.2 affects recognition by some but not all A3.2-alloreactive cytotoxic T cells.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_39fc33942ccd810d102e5a89b36b5f93"},{"public_id":"cl_27672f6cba000c2d1092b6b5440127fb","status":"active","text":"The A3.1 Leu at position 156 is sufficient for recognition by only one A3.1-allospecific cytotoxic T cell line.","confidence":0.94,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_27672f6cba000c2d1092b6b5440127fb"},{"public_id":"cl_69d7271167fc19a6dfde738c820c480b","status":"active","text":"The structural basis for epitopes recognized by almost all cytotoxic T cells that discriminate between HLA-A3.1 and HLA-A3.2 is primarily the amino acid at position 152.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_69d7271167fc19a6dfde738c820c480b"}],"concepts":[{"public_id":"co_0ac289d726de330b307304341f6f7e4b","status":"active","name":"A3.1-restricted cytotoxic T lymphocyte populations","description":"Cytotoxic T cell populations whose recognition depends on HLA-A3.1.","types":["immune cell population"],"aliases":["A3.1-restricted CTL"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0ac289d726de330b307304341f6f7e4b"},{"public_id":"co_28206c12ef8e532446d09896d3250a97","status":"active","name":"position 156","description":"Amino acid position 156 in the HLA-A3 molecule, where Leu in HLA-A3.1 and Gln in HLA-A3.2 differ.","types":["protein residue position"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_28206c12ef8e532446d09896d3250a97"},{"public_id":"co_355279238f49cca3d8a09e19708c9db6","status":"active","name":"DNA-mediated gene transfer","description":"A transfection approach used to express engineered HLA-A3 variants in mammalian cells.","types":["method"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_355279238f49cca3d8a09e19708c9db6"},{"public_id":"co_37b226c0c9e84ef4489e4a387fdde5cb","status":"active","name":"A3.1-allospecific cytotoxic T lymphocyte populations","description":"Cytotoxic T cell populations that recognize HLA-A3.1 as an alloantigen.","types":["immune cell population"],"aliases":["A3.1-allospecific CTL"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_37b226c0c9e84ef4489e4a387fdde5cb"},{"public_id":"co_3e495dca3a0db46f532e2e0096e02e74","status":"active","name":"HLA-A3.1","description":"One of two T cell-defined HLA-A3 subtypes used in the recognition analysis.","types":["HLA subtype"],"aliases":["A3.1"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3e495dca3a0db46f532e2e0096e02e74"},{"public_id":"co_3e641b32041e097b24075c0b0cb49d7c","status":"active","name":"site-directed mutagenesis","description":"A method used to introduce specific amino acid substitutions into the HLA-A3 molecule.","types":["method"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3e641b32041e097b24075c0b0cb49d7c"},{"public_id":"co_4ffdc97317f78dcd46066a42fdca8bbd","status":"active","name":"cytotoxic T cell line","description":"A cultured cytotoxic T cell population used as a recognition assay reagent.","types":["cell line"],"aliases":["CTL line"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4ffdc97317f78dcd46066a42fdca8bbd"},{"public_id":"co_5c0649dfc0defbd6a2c66ee6f72b3300","status":"active","name":"HLA-A3.2","description":"One of two T cell-defined HLA-A3 subtypes used in the recognition analysis.","types":["HLA subtype"],"aliases":["A3.2"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5c0649dfc0defbd6a2c66ee6f72b3300"},{"public_id":"co_718b28c64c30d6ba121e89d69efa464b","status":"active","name":"HLA-A3","description":"A human class I HLA molecule analyzed for its molecular basis of recognition by cytotoxic T cells.","types":["protein"],"aliases":["HLA-A3 molecule"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_718b28c64c30d6ba121e89d69efa464b"},{"public_id":"co_909cf6de645fd233277a6a830552e11d","status":"active","name":"A3.2-alloreactive cytotoxic T cells","description":"Cytotoxic T cells that react to HLA-A3.2 alloantigenic determinants.","types":["immune cell population"],"aliases":["A3.2-alloreactive CTL"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_909cf6de645fd233277a6a830552e11d"},{"public_id":"co_a0fcacc3940249c172bc8f1683ea01a8","status":"active","name":"position 152","description":"Amino acid position 152 in the HLA-A3 molecule, where Glu in HLA-A3.1 and Val in HLA-A3.2 differ.","types":["protein residue position"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_a0fcacc3940249c172bc8f1683ea01a8"},{"public_id":"co_a9efec194342201c0a5311626e793eaa","status":"active","name":"cytotoxic T lymphocytes","description":"T cells that recognize antigen-presenting cells and mediate target-cell killing.","types":["immune cell"],"aliases":["CTL"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_a9efec194342201c0a5311626e793eaa"}],"external_ids":{"DOI":"10.4049/jimmunol.141.4.1108","ArXiv":null,"PubMed":2456340,"PubMedCentral":null,"MAG":1633531602,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://journals.aai.org/jimmunol/article-pdf/141/4/1108/1041571/1108.pdf","landing_url":"https://www.semanticscholar.org/paper/3a10bf75b285668dad98ed7e7a14c04f3767933c","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":null,"status":"BRONZE","reason":null},"reference_availability":{"status":"unknown","references_indexed":false,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":635913,"paper_uid":"563536af-fa00-449a-a5aa-4e645e8e89ac","canonical_identity":{"paper_id":635913,"paper_uid":"563536af-fa00-449a-a5aa-4e645e8e89ac","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/31449428"}